Heart failure (HF) remains a major cause of morbidity and mortality. Heart transplantation
(HT) is a life-saving procedure for patients with advanced heart failure, but availability is …

Continuous-flow left ventricular assist devices (LVADs) have revolutionized advanced heart
failure care. These compact, fully implantable heart pumps are capable of providing …

Objectives: The purpose of this study was to determine the risk factors for ischemic in
hemorrhage cerebrovascular events in patients supported by the HeartWare ventricular …

The field of cardiothoracic transplantation (CT) has evolved significantly, but infections
remain an important cause of morbidity and mortality, particularly fungal infections (FIs). The …

Objectives: The feasibility of 18F-fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) for the diagnosis of left ventricular assist …

With the rising prevalence of heart disease in the United States, there is increasing reliance
on durable mechanical circulatory support (MCS) to treat patients with end-stage heart …

1. Background More than 20 years have passed since heart transplantation began to be
performed under the Organ Transplant Law enacted in 1997. The Law was amended to …

Background Drive-line infections and sepsis lead to significant morbidity and even mortality
in patients with ventricular assist devices (VADs). The HeartWare HVAD system is unique …

Abstract Aims Heart transplantation (HTx) represents optimal care for advanced heart failure.
Left ventricular assist devices (LVADs) are often needed as a bridge‐to‐transplant (BTT) …

Abstract The Infectious Diseases Community of Practice of the American Society of
Transplantation has published evidenced‐based guidelines on the prevention and …